Currently out of the existing stock ratings of Andrew D'silva, 75 are a BUY (93.75%), 5 are a HOLD (6.25%).

Andrew D'silva

Work Performance Price Targets & Ratings Chart

Analyst Andrew D'silva, carries an average stock price target met ratio of 59.09% that have a potential upside of 57.77% achieved within 270 days.

Andrew D'silva’s has documented 160 price targets and ratings displayed on 21 stocks. The coverage was on Healthcare, Industrials sectors.

Most recent stock forecast was given on OTRK, Ontrak at 20-Aug-2021.

Wall Street Analyst Andrew D'silva

Analyst best performing recommendations are on CYRX (CRYOPORT).
The best stock recommendation documented was for CYRX (CRYOPORT) at 8/24/2020. The price target of $45 was fulfilled within 2 days with a profit of $8.32 (22.68%) receiving and performance score of 113.41.

Average potential price target upside

of $13.95 (65.3%) on OPRX (OPTIMIZERX CORP).
of $8.93 (43.03%) on IIN (INTRICON).
of $8.82 (25.74%) on CYRX (CRYOPORT).

ADMP Adamis Pharma CLPT Clearpoint Neuro CRMD CorMedix CTSO Cytosorbents Crp CYRX Cryoport HROW Harrow Health IIN IntriCon INFI Infinity Pharmaceuticals LFMD LifeMD MPLN MultiPlan OPRX OPTIMIZERx Corp OTRK Ontrak VRAY ViewRay ALIM Alimera Sciences ANIX Anixa Biosciences EDAP EDAP TMS SA EYPT Eyepoint Pharmaceuticals ICAD icad inc KIN Kindred Biosciences ORMP Oramed Pharmaceuticals SRTS Sensus Healthcare

Show more stocks

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score